Pfizer Seeks US Authorization of COVID-19 Boosters for Latest Omicron Variants

Pfizer Seeks US Authorization of COVID-19 Boosters for Latest Omicron Variants
A health care worker prepares a dose of Pfizer BioNTech COVID-19 vaccine in a file image. Ezra Acayan/Getty Images
Updated:
0:00

Pfizer and partner BioNTech announced they have submitted a request to the U.S. Food and Drug Administration (FDA) to authorize a COVID-19 vaccine booster that has been updated to target the newest Omicron subvariants.

The request comes after the FDA in June advised COVID-19 vaccine makers to amend their shots to target the two Omicron subvariants BA.4 and BA.5, which are better than ever at dodging immunity from earlier vaccination or infection.
Related Topics